IGC Pharma
IGC
#10740
Rank
A$30.3 M
Marketcap
A$0.26
Share price
-4.61%
Change (1 day)
-50.10%
Change (1 year)
IGC Pharma, Inc. (formerly India Globalization Capital, Inc.) is a clinical-stage pharmaceutical company focused on developing advanced treatments for diseases, with a primary focus on Alzheimer's disease and other neurological conditions.

Earnings for IGC Pharma (IGC)

Earnings in 2026 (TTM): -A$9.75 Million

According to IGC Pharma's latest financial reports the company's current earnings are A$1.18 Million. In 2025 the company made an earning of -A$7.89 Million, an increase over its 2024 earnings that were of -A$13 Million. The earnings displayed on this page is the company's Pretax Income.

Earnings history for IGC Pharma from 2006 to 2026

Annual earnings

Year Earnings Change
2026 (TTM) -A$9.75 Million23.53%
2025 -A$7.89 Million-39.35%
2024 -A$13 Million-37.72%
2023 -A$20.88 Million1.19%
2022 -A$20.63 Million21.96%
2021 -A$16.92 Million27.13%
2020 -A$13.31 Million57.16%
2019 -A$8.47 Million85.47%
2018 -A$4.57 Million52.76%
2017 -A$2.99 Million-16.23%
2016 -A$3.57 Million-28.75%
2015 -A$5.01 Million-19.59%
2014 -A$6.23 Million6.79%
2013 -A$5.84 Million-9.47%
2012 -A$6.45 Million-74.03%
2011 -A$24.8 Million119.78%
2010 -A$11.29 Million62.02%
2009 -A$6.97 Million74.39%
2008 -A$4 Million-313.12%
2007 A$1.87 M-35.94%
2006 A$2.92 M

Earnings for similar companies or competitors

Company Earnings Earnings differencediff. Country
Sterling Infrastructure
STRL
A$1.15 B-12,021.75%๐Ÿ‡บ๐Ÿ‡ธ USA
Trinity Industries
TRN
A$1.07 B-11,253.02%๐Ÿ‡บ๐Ÿ‡ธ USA
Granite Construction
GVA
-A$0.22 Billion 2,142.84%๐Ÿ‡บ๐Ÿ‡ธ USA